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Foreword
CUBRC has developed an in-line, multi-analyte isolation technology that utilizes solid phase extraction chemistries to purify and concentrate nucleic acids and protein for downstream analysis. This technology will be automated by developing a single use, cartridge-based unit. Development of such a unit is critical to reaching the US Government's and Department of Defense's biological threat countermeasure development goals. Specifically, CUBRC will design and manufacture a prototype cartridge(s) and test the prototype cartridge for its ability to isolate each analyte individually and in succession. Testing will be performed on both laboratory derived samples and samples typical of those generated by aerosol collectors. The goal of this program is to advance CUBRC's multi-analyte sample preparation technology into a single-use cartridge format. This program will design, manufacture and test a prototype cartridge for sequential nucleic acid and protein isolation from a sample. List of Tables and Figures  Table 1  6  Table 2  9  Table 3 10 Figure 1 7 Figure 2 8
Statement of the problem studied CUBRC, Inc. has developed a rapid method to sequentially isolate pure nucleic acids and protein from virtually any sample type. This technology is extremely important for both the detection and diagnostic capabilities of the US Government and Department of Defense. The democratization of advanced science and technology combined with the threat posed by terrorism and rogue nations has led to an urgent need to develop appropriate countermeasures to threats posed by biological agents, including natural, emerging and engineered agents. Biological threat agents are comprised of a large number of diverse organisms leading to unique and challenging problems when developing countermeasures. One of these problems is correct identification or diagnosis of a particular threat agent. There have been extraordinary advances made in the detection, identification and diagnostic fields in response to this recognized problem. Despite these advances, barriers to a complete set of countermeasures remain. One such barrier is posed by the apparent disconnect between the identifier or diagnostic device and the actual sample to be tested. This disconnect can be seen when highly sensitive identifiers or diagnostic devices fail to recognize an agent because samples contain interferents or inhibitors that prevented proper function of the molecular tools employed by the identification device. In an attempt to remove interferents and inhibitors, many device developers have determined a preparation step is required to remove interferents and inhibitors prior to testing the sample in their devices Sample preparation refers to the isolation of an analyte or macromolecule class such as nucleic acids from the sample milieu. Sample preparation presents an identifier or diagnostic device with clean analytes which in turn improves the sensitivity and accuracy of the technology. There are a large number of sample preparation technologies and devices on the market today, however most have one or more limitations that prevent them from being widely accepted by the communities charged with their use [1] [2] [3] . Typically, the nucleic acid isolation kits produced by Qiagen are considered the industry standard however they are designed for laboratory use, require laboratory tools, and are not well suited for field or high-throughput applications. CUBRC, Inc. has developed a sample preparation technology that overcomes these limitations. Our sample preparation technology is based on the well-known BOOM® chemistry that isolates nucleic acids by a silica-based solid state mechanism [4] . We have developed a similar solidphase extraction chemistry to purify protein from a sample following nucleic acid isolation [5] . CUBRC's sample preparation technology is unique in that both the nucleic acid and protein content of a sample can be isolated sequentially. Also unique to our technology is the form factor of the solid phase extraction matrix. Both solid phase extraction chemistries utilize a silica-based matrix that has been placed into a pipette tip. In this form, the user simply pipettes the sample through the matrix. Depending on the chemistries used, either the nucleic acid or protein content of the sample selectively binds to the silica matrix. The sample can be passed through the matrix multiple times to increase binding with the matrix. The form factor of our silica matrix eliminates the need for bulky or sensitive laboratory equipment and requires only a pipettor. This form factor also reduces the time needed for isolation, as nucleic acids can be isolated in under 5 minutes and both nucleic acids and protein in under 20 minutes. Importantly, because the matrix is simply built into a cylindrical fitting and liquid flowed over it, it is very amenable to automation.
Automation of our analyte isolation technologies is a straightforward process that is progressing along two paths. The first path is to build single-use cartridges that will process a sample, without user intervention, for the two analyte types. This cartridge will be fit into a device containing all of the necessary software and pumps to drive the fluidics for sample processing. The second path is to simply fit the matrix into pipette tips that are designed for high throughput robotics platforms. These platforms could rapidly isolate samples for triage or confirmatory analysis in hospital or mobile laboratory settings. This program will design, manufacture, and test a prototype cartridge thus advancing development of the automated cartridge platform beyond its current breadboard configuration.
Macromolecule Isolation Performance Data: Nucleic Acid Isolation:
The nucleic acid isolation procedure is performed using a form modification of the well-characterized chaotropic salt/silica chemistry (BOOM® chemistry). As stated previously, the form modification is the utilization of a cylindrical pipette with a silica-based capture matrix embedded within. This form factor is known as the TruTip™. Captured nucleic acids are eluted from the matrix with the provided elution buffer or any buffer preferred by the user. Generally, the elution volume (100-250 L) is smaller than the sample volume, leading to a concentration of the target analyte; nucleic acids in this case. The TruTip™ method is compatible with all known elution buffers (typically aqueous solutions) and therefore can accommodate the requirements of any downstream detection or diagnostic device. After a short set-up procedure where the user measures out reagents into the proper tubes, the user need only pipette for multiple cycles in the proper buffer to extract PCR-ready nucleic acids. Nucleic acid isolation using the TruTip™ is the best characterized and tested of the TruTip™ capabilities.
In head-to-head evaluations the TruTip™ technology was shown to positively ID assorted bacteria and viruses as reliably as the current industry goldstandard, Qiagen. The data in Table 1 , upper and lower panels, were obtained using Qiagen kits specific to the organism of interest whereas the TruTip™ protocol was identical for each organism. These data show that the single TruTip™ protocol was as efficient as the Qiagen kits at extracting PCR ready nucleic acids from a sample. The data in the upper panel was obtained using vegetative Bacillus anthracis spiked into whole blood at a concentration of 10 3 CFU/mL. Thirty samples were processed using the TruTip™ protocol and another 30 samples were processed using the Qiagen Genomic DNA kit. The data show that both kits extracted PCR-ready target DNA from all samples and that the amount of DNA, as measured by the average CT, was identical. A similar experiment was performed using Venezuelan equine encephalitis virus (VEE virus) at a concentration of 10 4 PFU/mL in whole blood. In this case, the Qiagen Viral RNA kit was required whereas a common TruTip™ protocol was employed for comparison. As with the previous experiment, the data show an identical amount of PCR-ready nucleic acid was isolated. Overall, these experiments indicate that the TruTip™ method extracts nucleic acids for PCR-analysis with equal efficiency to the industry gold standard, requires significantly less time per sample, can be applied to all viral and bacterial targets studies without adjusting the protocol, and does not require cumbersome laboratory equipment.
The TruTip™ nucleic acid isolation technology has been developed to be compatible with a multitude of sample matrices. The list below identifies the compatible matrices that have been identified to date:

For all of the identified matrices, the standard TruTip™ nucleic acid isolation procedure worked well however some adjustments may improve the yield from each sample type. For instance, a preliminary homogenization step for sputum or soil matrices has been shown to improve the flow of the sample though the capture matrix thus maximizing the flow rate while increasing the capture efficiency. The TruTip™ nucleic acid extraction technology has been developed into a prototype integrated sample preparation/identification cartridge for use with the TruDx suite of instruments from Akonni Biosystems ( figure 1 ). This prototype cartridge is under evaluation by Akonni Biosystems and has performed admirably compared to the handheld, TruTip™ unit, outperforming the handheld units in many cases. The design of the sample preparation portion of this prototype will be incorporated into the CUBRC prototype.
To conclude, the TruTip™ nucleic acid isolation procedure is a simple, yet robust method to isolate nucleic acids both in the lab and in the field. The procedure is compatible with multiple matrices and all pathogenic organisms. The design of the TruTip™ has made it extremely amenable to automation and compatible with cartridge development.
Protein Isolation: The TruTip™ nucleic acid & protein isolation technology is the only marketed kit capable of sequentially isolating both protein and nucleic acids. The "waste" from the nucleic acid isolation is added to the protein isolation buffer. This buffer is an alcohol solution that strips the shell of hydration from the protein within the sample. Our alcohol based buffer is similar in principle to the ethanol precipitation of protein from guanidine solutions described by Pepinsky [6] . The protein is isolated by binding to a second silica matrix. Using the identical silica capture matrix material for protein and nucleic isolation simplifies the product for the user while reducing logistical burdens.
CUBRC has also demonstrated the field deployability of the handheld version of this technology by isolating nucleic acid and protein from Yersinia pestis (avirulent A1122 strain) samples and identifying the resultant protein analyte on a Y. pestis specific hand-held assay from Tetracore ( Figure 1) . The data from the hand-held assays show that the samples isolated using the TruTip™ isolation process were able to identify Y. pestis at a concentration of 10 4 CFUs which is an order of magnitude lower than that in samples that were not processed. These data speak to the TruTip™ isolation method's ability to concentrate and purify the analyte of interestprotein in this case.
To conclude, the protein isolation technique performed sequentially, post-nucleic acid isolation, allows the user to test multiple analyte types from the same sample without splitting the sample.
Benefit to the Warfighter: The development of a simple, robust technology that isolates two distinct macromolecule classes from most matrices for downstream identification and analysis is critical for today's Warfighter. As the Warfighter is confronted with the challenges posed by biological warfare and terrorism, new methods to rapidly "detect to protect" are needed. Sample preparation is a critical step in this pathway. By simplifying the isolation technologies and removing the majority of user handling steps, the CUBRC automated sample preparation (ASP) system provides a rapid, reliable and standardized process for biological threat agent sensing. By providing multiple types of macromolecules for analysis, the CUBRC ASP system provides the Warfighter a measure of redundancy not seen in any other system in today's market.
Summary of the most important results
The CUBRC team has designed and built an automated nucleic acid and protein isolation device, the '380,' and has developed single use cartridges to process eight samples, simultaneously. The '380' has been developed from concept stage through computer aided design to the bechtop prototypes shown in figure 2. The biomarker isolation chemistries and protocols have been fully developed. In addition, protocols have been written into the software developed specifically to control the '380.' This software is compatible with the Windows XP and Windows 7 operating systems and provides the user with a simple "point-and-click" method of operation. The protocols that we are using to isolate nucleic acids followed by protein from a sample are similar to the protocol that we've developed and published for our hand-held extraction device [7] . Our protocols we're converted to a text format compatible with the '380' software (Appendix C). Without going into detail, there are a number of variables that are manipulated by the '380' which are controlled from a single interface and fairly simple alter as necessary.
During testing, we did find a weakness in the '380' design. The attachment nozzles for the solid phase extraction tips broke on three occasions. The nozzles were redesigned and a new manifold assembled. This new design has performed well, with no breakages and identical extraction data to the original (see 2012 Q3 DTRA report).
Multi-analyte extraction, DNA isolation analysis:
The results for comparative DNA extractions of Bacillus globigii spores using three devices have been analyzed by qrtPCR and reported in table 2 below. These results were obtained from 3 separate triplicate extractions, meaning each data point was from determined by the average of 9 total samples. We also utilized two different buffers, Joint Portal Shield Buffer (JPSB) and our in-house Automated Sample Preparation buffer (ASP buffer). The qrtPCR results proved very interesting. Importantly, all of the controls (white columns) were very consistent and tightly clustered with standard deviations of approximately 5%. The '380' system (yellow columns) appeared to perform very well in terms of isolating and concentrating DNA as the calculated recovered DNA was far higher than the input DNA concentration. However, it is important to note that the consistency of extraction was poor as can be seen by the standard deviations for Ct values ranging from 30-50% of the average value. The handheld TruTip device (green columns) performed consistently (Ct standard deviations averaging 2-2.5%) in this study however the TruTip did not isolate the amount of input DNA nor did it concentrate the DNA. Finally, the DNAPro (blue columns), performed consistently in both the amount of DNA isolated as a function of input DNA and the standard deviation as a function of Ct value. One important note is that the performance could be affected by the buffer solution. For instance, the DNAPro appears to perform better when the diluent was Joint Portal Shield Buffer. This relationship did not appear to hold true for the '380' or the TruTip where there was no statistically relevant difference.
Multi-analyte extraction, protein isolation analysis:
The results of three dot blot extractions performed in triplicate are tabulated as a percentage of positive identifications at each Bacillus globigii spore lysate titer in the table below. These results show that the protein isolated using the "380" automated system is "concentrated" minimally 10-fold and likely more so. The chemistries that we developed for protein isolation are clearly amenable to the handheld devices as well. In particular, the chemistries work well with the DNAPro handheld device which is an electricity-free extraction tool. It is important to note that, due to volume constraints, the "380" system uses only 40% of the input that the handheld devices use. Thus, the drop-off in detection efficiency using the "380" with ASP buffer may simply due to less antigen supplied to the system and not a deficiency in the system's ability to isolate the antigen.
When taken together, these data show that the '380' system in conjunction with JPSB provides the most sensitive results though somewhat less consistent when using qrtPCR. The '380' paired with JPSB also provides very consistent results and increased sensitivity for protein detection assays when coupled with nucleic acid isolation. In the final analysis, the '380' system provides an excellent platform for the dual extraction of nucleic acids and proteins from a sample, thus enabling the warfighter with increased confidence of results through redundant identification tools. 
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